Focused Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,000
Closed -$2.16K 1162
2023
Q1
$2.16K Hold
6,000
﹤0.01% 789
2022
Q4
$5.32K Sell
6,000
-8,000
-57% -$10.6K ﹤0.01% 630
2022
Q3
$22K Hold
14,000
﹤0.01% 385
2022
Q2
$28K Hold
14,000
0.01% 350
2022
Q1
$33K Buy
14,000
+8,000
+133% +$25K 0.01% 358
2021
Q4
$28K Sell
6,000
-5,500
-48% -$34.1K ﹤0.01% 445
2021
Q3
$88K Buy
11,500
+1,500
+15% +$12.7K 0.01% 312
2021
Q2
$97K Sell
10,000
-1,230
-11% -$9.79K 0.02% 295
2021
Q1
$93K Sell
11,230
-1,000
-8% -$10.6K 0.02% 289
2020
Q4
$83K Buy
12,230
+230
+2% +$1.85K 0.02% 294
2020
Q3
$134K Hold
12,000
0.03% 191
2020
Q2
$75K Buy
12,000
+4,000
+50% +$15.3K 0.02% 262
2020
Q1
$15K Buy
8,000
+6,500
+433% +$18.7K ﹤0.01% 415
2019
Q4
$5K Buy
+1,500
New +$3.58K ﹤0.01% 585

Other funds holding SRNE